TrialThe Lancet. Oncology2013

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Viviana Galimberti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.